India: NPPA Revises Coronary Stent Price After A Year Of Price Cap

The National Pharmaceutical Pricing Authority (NPPA) is under constitutional obligation to provide fair, reasonable and affordable price for Coronary Stents and to check unethical profiteering and exploitive pricing. In order to protect public interest in extraordinary circumstances under paragraph 19 of the Drug Pricing Control Organization (DPCO), 2013, NPPA fixed the ceiling price of cardiac stent for the first time and notified the same vide S.O. 412 (E) dated February 13, 2017 for a year4.

NPPA, further in various meetings and discussions with expert committee and all concerned stakeholders/ organizations against the concerns of sub-classification of drug eluting stents (DES), rewarding incremental innovation, an upward revision or no change in the ceiling price in ceiling prices, increase in trade margins and freedom to withdraw unviable brands from Indian market, has observed some key points that:

  • There was an increased indigenous manufacturing activity and enhanced imports and availability of cardiac stents made in India in year 2017. There was a clear overall 5% growth in the indigenously manufactured stents.
  • The year 2017 witnessed an overall marginal increase of 1% in imports of stents from US based manufacturers while as much as 35% increase in imports of stents from non-US manufacturers was seen.
  • The year 2017 also saw entry of some new companies, both Indian and foreign like USA, Singapore, Spain, China and UK having its manufacturing primarily in UAE, in the market.
  • The decision of putting only 8% trade margins cap eliminated almost all unethical payment and profiteeringin the system and also disrupted status quo in trade of stents which was based on profiteering at each level.

NPPA finally concluded that cardiac stents are an essential drug under Schedule I of DPCO, 2013 and part of NLEM, 2015 and have paramount importance on public health. Therefore, the category needs to continue to be kept under price regulation in larger public interest5.

Further, on February 12, 20186, NPPA revised the ceiling prices of drug eluting stents (DES) to Rs 27,890 from Rs. 29,600, while marginally raising the cap on bare metal stents to Rs 7,660 from Rs 7,260 as listed below:

S.No. Coronary Stents
(Sl. 31 in Schedule I of DPCO 2013)
(in Number)
Ceiling Price
(In Rs.)
1 Bare metal stents 1 7,660
2 Drug Eluting Stents (DES) including metallic DES and Bioresorbable Vascular Scaffold (BVS)/ Biodegradable Stents 1 27,890

Trade margin & GST on revised stent price:

GST: The manufacturers may add goods and services tax and no other charges in the calculation of MRP, if they have actually paid such taxes or if it is payable to the Government on the ceiling price specified in the above table.

Trade margin:

The revised ceiling prices are inclusive of 8% maximum permissible trade margin which is sacrosanct and no additional charge whatsoever, over and above the ceiling price specified hereinabove, in the price notification shall be charged from the consumer/patient except applicable goods and services tax, if any, paid or payable. Trade margin in excess of 8% specified above, in whatsoever form, shall be construed as 'violation' and whoever is involved in such transactions, jointly and severally, shall be liable to appropriate action including prosecution, for violation of the provisions of the DPCO, 2013 under the Essential Commodities Act, 1955.

Monitoring Price of Essential Accessories used during angioplasty

Various accessories like cardiac catheters, balloon catheters and guide wires are integral part of the angioplasty package and are necessarily used during angioplasties. NPPA took serious note of trade margins of these essential accessories and decided further monitoring of their respective MRPs not only on the basis of manufacturer's data but also the retail usage data.

NPPA directed all healthcare institutions, which are performing angioplasty and billing the patients, to mention cost of cardiac catheters, balloon catheter and guide wire separately along with their respective brand name, company name, batch number and specifications in order to bring in greater transparency in the billing and monitoring of compliance with the MRPs set by the NPPA under Para 20 of DPCO, 2013.

Industry compliance with revised ceiling price

The revised ceiling price as specified above shall be applicable from February 13, 2018, and shall also be applicable to all the stocks of coronary stents including "Covered coronary stents "available for sale in the trade channel. In this regard –

  • All manufacturers/marketers of above coronary stents are advised to revise the price of all such stents, plus goods and services tax as applicable and paid, if any.
  • The manufacturers under Paragraph 24 of DPCO, 2013 shall issue price list in Form–V to the NPPA through online Integrated Pharmaceutical Database Management System (IPDMS) along with a certified hard copy, and submit a copy of the same to all the State Drug Controllers and all its distributors/dealers/ cardiac healthcare institutions performing angioplasties.
  • All the manufacturers will continue to ensure the availability of all the brands of coronary stents and ensure that no disruption is caused in the supply chain.
  • Every distributor, dealer and institution shall display price list and the supplementary price list, if any, as furnished by the manufacturer/importer, on a conspicuous part of the premises where he carries on business including its publication on its website.
  • Since cardiac catheters are necessarily used during angioplasties and are integrated part of the angioplasty package; healthcare institutions which are performing angioplasty and billing the patients, shall also mention cost of cardiac catheters, balloon catheter and guide wire separately.
  • No healthcare institution, such as hospitals/nursing-homes/clinics performing angioplasty procedures using coronary stents, shall solicit any patient to purchase coronary stents from it, in case, the patient is interested in procuring such stents from any other third-party sources.


  • Any manufacturer intending to discontinue production or import of any Coronary Stent shall furnish information to the NPPA, in respect of discontinuation of production and / or import in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation as prescribed under paragraph 21(2) of the DPCO, 2013 and follow the ceiling price in such manner and till such a time prescribed by the Government.
  • The revised ceiling price hereinabove shall be applicable till March 31, 2019, unless revised by another notification.





The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions